Boston, MA, United States of America

Brian M Andresen



 

Average Co-Inventor Count = 10.0

ph-index = 7

Forward Citations = 125(Granted Patents)


Location History:

  • Menlo Park, CA (US) (2015)
  • Boston, MA (US) (2017 - 2020)
  • Sharon, MA (US) (2013 - 2023)

Company Filing History:


Years Active: 2013-2023

where 'Filed Patents' based on already Granted Patents

23 patents (USPTO):

Title: Brian M. Andresen: Innovator in Cyclic di-Nucleotide Compounds

Introduction: Brian M. Andresen is a prominent inventor based in Boston, MA, recognized for his significant contributions to the field of pharmaceuticals and biotechnology. With an impressive portfolio of 23 patents, Brian has made notable advancements in the development of cyclic di-nucleotide compounds, which hold promise in enhancing immune responses.

Latest Patents: Among Brian's latest innovations are two pivotal patents focused on cyclic di-nucleotide compounds as STING (Stimulator of Interferon Genes) agonists. The first patent presents a class of polycyclic compounds defined by a specific formula, detailing their potential use as inductors of type I interferon production. These compounds are particularly valuable as STING active agents. The second patent similarly describes another class of polycyclic compounds, reiterating their utility in stimulating the immune response and detailing the processes for their synthesis and application.

Career Highlights: Brian's career has seen him collaborate with leading companies in the pharmaceutical sector, notably Merck Sharp & Dohme Corporation and Lycera Corporation. His work in these companies has contributed significantly to the advancement of therapeutic compounds in the market.

Collaborations: In his professional journey, Brian has worked alongside esteemed colleagues such as Michael D. Altman and Alan B. Northrup, sharing insights and expertise that have propelled their research forward.

Conclusion: Brian M. Andresen stands out as an influential figure in the development of cyclic di-nucleotide compounds, showcasing a commitment to innovation and collaboration in his field. His patents not only reflect his ingenuity but also highlight the potential for these compounds to impact healthcare positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…